| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥258.9B | ¥264.1B | -2.0% |
| Operating Income | ¥9.5B | ¥5.3B | +79.6% |
| Ordinary Income | ¥10.1B | ¥5.9B | +70.4% |
| Net Income | ¥6.8B | ¥3.7B | +83.0% |
| ROE | 4.0% | 2.2% | - |
FY2026 Q3 results: Revenue 258.9B yen (YoY -2.0%), Operating Income 9.5B yen (+79.6%), Ordinary Income 10.1B yen (+70.4%), Net Income 6.8B yen (+83.0%). Despite a slight revenue decline, the company achieved significant profit expansion through improved gross margin and controlled selling, general, and administrative expenses. Gross profit margin improved to 14.1%, while SG&A ratio was maintained at 10.4%, resulting in operating margin expansion to 3.7% from 2.0% in the prior year. The profit improvement reflects effective cost management and operational leverage. Basic EPS increased 83.0% to 148.59 yen from 81.20 yen YoY. Total assets increased to 262.3B yen from 252.0B yen, while equity strengthened to 170.6B yen from 165.2B yen, maintaining a solid equity ratio of 65.0%.
Revenue decreased 2.0% YoY to 258.9B yen from 264.1B yen, reflecting a modest top-line contraction. Despite the revenue decline, gross profit increased by 3.6B yen as cost of sales decreased more substantially than revenue, improving gross margin to 14.1% from 10.5% YoY, representing a 3.6 percentage point improvement. This margin expansion was primarily driven by cost management initiatives and improved operational efficiency. SG&A expenses remained flat at 26.9B yen with the ratio improving to 10.4% from 10.2% YoY due to the revenue base effect. Operating income surged 79.6% to 9.5B yen from 5.3B yen, with operating margin expanding 1.7 percentage points to 3.7% from 2.0% YoY. Non-operating income contributed a net 0.6B yen, comprising dividend income of 0.2B yen and other non-operating income of 0.3B yen, with minimal non-operating expenses of 0.1B yen. Ordinary income reached 10.1B yen, up 70.4% YoY. Income tax expense was 3.3B yen, representing an effective tax rate of approximately 32.7%. Net income attributable to owners increased 83.0% to 6.8B yen from 3.7B yen. The pattern represents revenue down/profit up, driven by successful cost restructuring and gross margin improvement despite challenging top-line conditions.
The company operates in a single segment (chemicals business), therefore segment-level analysis is not applicable.
[Profitability] ROE of 4.0% remains modest but reflects improvement from prior levels, supported by net profit margin expansion. Operating margin of 3.7% improved 1.7 percentage points from 2.0% YoY, demonstrating enhanced operational efficiency. Gross profit margin of 14.1% represents a 3.6 percentage point improvement from 10.5% YoY, indicating successful cost management. Net profit margin reached 2.6%, expanding from 1.4% in the prior year. [Cash Quality] Cash and deposits of 66.1B yen provide coverage of 22.0x against short-term debt of 3.0B yen, indicating robust liquidity. [Investment Efficiency] Asset turnover of 0.99 reflects near-complete asset utilization relative to revenue. Financial leverage of 1.54x indicates conservative capital structure. [Financial Health] Equity ratio of 65.0% demonstrates strong capitalization and financial stability. Current ratio of 226.1% and quick ratio of 222.5% indicate excellent short-term liquidity. Debt-to-equity ratio of 0.54 reflects minimal leverage with total liabilities of 91.7B yen against equity of 170.6B yen.
Cash and deposits increased to 66.1B yen, representing 25.2% of total assets, indicating strong liquidity maintenance. Trade receivables of 83.3B yen represent 32.2 days of sales outstanding calculated on a quarterly basis, or approximately 117 days annualized, reflecting extended collection cycles that warrant monitoring for working capital efficiency. Inventories increased by 1.0B yen to 3.2B yen for finished goods, suggesting either demand anticipation or sales timing effects. Trade payables of 47.1B yen provide effective supplier credit utilization. The balance sheet reflects working capital expansion with current assets increasing to 203.5B yen. Retained earnings grew to 152.1B yen, reflecting profit accumulation and conservative dividend policy. The company's cash position of 66.1B yen against minimal interest-bearing debt of 3.0B yen indicates net cash status and financial flexibility for strategic investments or shareholder returns.
Ordinary income of 10.1B yen versus operating income of 9.5B yen shows net non-operating contribution of approximately 0.6B yen. This comprises primarily dividend income of 0.2B yen and other non-operating income of 0.3B yen, with negligible interest income and minimal non-operating expenses of 0.1B yen. Non-operating income represents 0.2% of revenue, indicating core earnings are predominantly driven by operational performance. Comprehensive income of 7.2B yen includes valuation gains on securities of 0.7B yen and remeasurement losses on defined benefit plans of 0.3B yen, adding 0.4B yen to net income. The composition indicates high-quality earnings with minimal reliance on non-recurring items or financial engineering. Operating profit expansion is attributable to recurring margin improvement rather than extraordinary gains.
Full-year guidance projects revenue of 360.2B yen (+3.8% YoY), operating income of 9.9B yen (+23.9% YoY), and ordinary income of 10.5B yen (+20.0% YoY). Q3 cumulative revenue of 258.9B yen represents 71.9% progress toward full-year guidance, slightly ahead of the standard 75% benchmark for Q3, suggesting modest revenue conservatism or fourth-quarter seasonality. Operating income of 9.5B yen represents 96.1% progress, significantly exceeding the standard 75% benchmark, indicating either outperformance in first nine months or potential fourth-quarter headwinds embedded in guidance. Ordinary income of 10.1B yen achieves 96.2% of full-year target. The company has not revised guidance this quarter, maintaining its full-year outlook despite strong Q3 profit performance. This suggests management conservatism or visibility into fourth-quarter factors that may moderate profit momentum.
The company forecasts an annual dividend of 40.00 yen per share for the full fiscal year. Based on forecast EPS of 157.37 yen, this implies a payout ratio of approximately 25.4%, reflecting a conservative distribution policy. The dividend policy allows substantial earnings retention for reinvestment or balance sheet strengthening. With net cash position and strong equity base, dividend sustainability appears secure even under moderate earnings volatility scenarios.
Extended receivables collection cycle with DSO of 117 days creates working capital pressure and exposes the company to customer credit risk, potentially constraining cash conversion despite profit growth. Low gross margin structure at 14.1% provides limited buffer against raw material cost inflation or pricing pressure, making profitability vulnerable to external cost shocks or competitive dynamics. Concentration in single-segment chemicals business limits diversification benefits and exposes earnings to sector-specific demand cycles and industry headwinds without offset from alternative revenue streams.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 4.0% (Industry Median 5.8%, below median). Operating Margin 3.7% (Industry Median 8.9%, significantly below median). Net Profit Margin 2.6% (Industry Median 6.5%, below median). The company's profitability metrics remain below manufacturing sector medians, indicating room for improvement in operational efficiency and pricing power despite recent margin expansion.
Financial Health: Equity Ratio 65.0% (Industry Median 63.8%, slightly above median). Current Ratio 226.1% (Industry Median 287.0%, below median but still strong). The company maintains solid capitalization in line with industry standards.
Efficiency: Asset Turnover 0.99 (Industry Median 0.56, significantly above median). Receivables Turnover 117 days (Industry Median 85 days, extended collection cycle). Payables Turnover estimated at 77 days (Industry Median 56 days). Operating working capital management shows mixed performance with efficient asset utilization offset by extended receivables.
Growth: Revenue Growth -2.0% (Industry Median +2.8%, below median). EPS Growth +83.0% (Industry Median +9.0%, significantly above median driven by margin recovery).
Returns: Financial Leverage 1.54x (Industry Median 1.53x, in line). ROIC estimated at 5.5% (Industry Median 6.0%, slightly below median).
※ Industry: Manufacturing (105 companies), Comparison: FY2025-Q3, Source: Proprietary analysis
Profit recovery driven by structural margin improvement rather than revenue growth represents the primary earnings characteristic, with gross margin expansion of 3.6 percentage points demonstrating successful cost restructuring initiatives that may provide sustainable competitive advantage if maintained. The company's net cash position of 63.1B yen (cash minus debt) combined with conservative 25% payout ratio creates substantial financial flexibility for growth investments, M&A, or enhanced shareholder returns, though capital allocation strategy remains unclear. Extended receivables cycle of 117 days versus industry median of 85 days highlights operational inefficiency that, if addressed, could unlock significant working capital and improve cash conversion without requiring revenue growth.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.